oliver_leatham

MSI appoints new market access consultant

pharmafile | May 22, 2012 | Appointment | Business Services, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, appointment, market access 

Strategic marketing firm The MSI Consultancy has appointed Oliver Leatham as market access consultant.

Oliver has a wide experience as a market access consultant and market research specialist, including being market research director at Clark Medical, ABN manager at BMS Pharmaceuticals, and NHS liaison manager with Abbott.

MSI managing director Jon Bircher, said: “The role of effective market access in pharma is becoming ever more important as a core component of any successful marketing strategy, and this is reflected in the strengthening of our specialist international market access team.  

“Oliver brings really strong experience in this field across geographies, in the industry and as a consultant and is already proving to be an excellent part of our growing team.”

Advertisement

Related Content

CSL Behring’s therapy for hereditary angioedema receives positive assessment in Germany

CSL Behring has announced a key milestone for its hereditary angioedema (HAE) therapy, garadacimab, following …

handshake_2

AOTI achieves broad market access in Germany for diabetic foot ulcer therapy

AOTI, focused on solutions for severe and chronic wounds, has announced that its unique topical …

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

The Gateway to Local Adoption Series

Latest content